
Journal of Functional Foods, Год журнала: 2024, Номер 123, С. 106608 - 106608
Опубликована: Ноя. 28, 2024
Язык: Английский
Journal of Functional Foods, Год журнала: 2024, Номер 123, С. 106608 - 106608
Опубликована: Ноя. 28, 2024
Язык: Английский
Stem Cell Research & Therapy, Год журнала: 2024, Номер 15(1)
Опубликована: Май 31, 2024
In the past decade, intestinal organoid technology has paved way for reproducing tissue or organ morphogenesis during physiological processes in vitro and studying pathogenesis of various diseases. Intestinal organoids are favored drug screening due to their ability high-throughput cultivation closer resemblance patient genetic characteristics. Furthermore, as disease models, find wide applications diagnostic markers, identifying therapeutic targets, exploring epigenetic mechanisms Additionally, a transplantable cellular system, have played significant role reconstruction damaged epithelium conditions such ulcerative colitis short bowel syndrome, well material exchange metabolic function restoration. The rise interdisciplinary approaches, including organoid-on-chip technology, genome editing techniques, microfluidics, greatly accelerated development organoids. this review, VOSviewer software is used visualize hot co-cited journal keywords trends firstly. Subsequently, we summarized current modeling, screening, regenerative medicine. This will deepen our understanding further explore intestine
Язык: Английский
Процитировано
8CABI eBooks, Год журнала: 2025, Номер unknown, С. 118 - 142
Опубликована: Март 24, 2025
Язык: Английский
Процитировано
0Clinical Microbiology Reviews, Год журнала: 2025, Номер unknown
Опубликована: Апрель 22, 2025
SUMMARY Recent advances in therapeutic probiotics have shown promising results across various health conditions, reflecting a growing understanding of the human microbiome’s role and disease. However, comprehensive reviews integrating diverse effects subjects been limited. By analyzing randomized controlled trials (RCTs) meta-analyses, this review provides overview key developments probiotic interventions targeting gut, liver, skin, vaginal, mental, oral health. Emerging evidence supports efficacy specific strains combinations treating wide range disorders, from gastrointestinal (GI) liver diseases to dermatological bacterial vaginosis, mental diseases. We discuss expanding microbiome-organ connections underlying mechanisms action. While many clinical demonstrate significant benefits, we acknowledge areas requiring further large-scale studies establish definitive optimal treatment protocols. The addresses challenges standardizing research methodologies emphasizes importance considering individual variations microbiome composition host genetics. Additionally, explore emerging concepts such as oral-gut-brain axis future directions, including high-resolution profiling, host-microbe interaction studies, organoid models, artificial intelligence applications research. Overall, offers update on current state multiple domains health, providing insights into directions potential for revolutionize preventive medicine.
Язык: Английский
Процитировано
0Frontiers in Immunology, Год журнала: 2024, Номер 15
Опубликована: Окт. 25, 2024
Artemisinin and its derivatives are widely recognized as first-line treatments for malaria worldwide. Recent studies have demonstrated that artemisinin-based antimalarial drugs, such artesunate, dihydroartemisinin, artemether, not only possess excellent properties but also exhibit antitumor, antifungal, immunomodulatory effects. Researchers globally synthesized artemisinin like SM735, SM905, SM934, which offer advantages low toxicity, high bioavailability, potential immunosuppressive properties. These compounds induce immunosuppression by inhibiting the activation of pathogenic T cells, suppressing B cell antibody production, enhancing differentiation regulatory cells. This review summarized mechanisms analogs modulate excessive inflammation immune responses in rheumatic skeletal diseases, autoimmune inflammatory disorders, through pathways including TNF, Toll-like receptors, IL-6, RANKL, MAPK, PI3K/AKT/mTOR, JAK/STAT, NRF2/GPX4. Notably, context NF-κB pathway, inhibits expression disrupting upstream cascades and/or directly binding to downregulates multiple downstream genes controlled NF-κB, chemokines their receptors. targets regulate various functions, apoptosis, proliferation, signal transduction, antioxidant responses, ultimately intervening systemic diseases organs kidneys, nervous system, skin, liver, biliary system modulating dysregulation responses. Ongoing multicenter randomized clinical trials investigating effects these on rheumatic, inflammatory, with aim translating promising preclinical data into applications.
Язык: Английский
Процитировано
2Heliyon, Год журнала: 2024, Номер 10(17), С. e37053 - e37053
Опубликована: Сен. 1, 2024
Язык: Английский
Процитировано
1Phytomedicine, Год журнала: 2024, Номер 135, С. 156136 - 156136
Опубликована: Окт. 9, 2024
Язык: Английский
Процитировано
0Journal of Functional Foods, Год журнала: 2024, Номер 123, С. 106608 - 106608
Опубликована: Ноя. 28, 2024
Язык: Английский
Процитировано
0